The Effect of Obesity on the Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2019
Price : $35 *
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastro-oesophageal reflux; Obesity
- Focus Pharmacokinetics
- 06 Jun 2019 Status changed from recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 06 Jan 2015 Planned End Date changed from 1 Dec 2014 to 1 Jul 2015 as reported by ClinicalTrial.gov record.